您的位置: 首页 > 农业专利 > 详情页

CELL THERAPY WITH LENTIVIRAL TRANSDUCED CSF2RA TRANSGENE IN THE TREATMENT OF HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS
专利权人:
MEDIZINISCHE HOCHSCHULE HANNOVER;CHILDREN'S HOSPITAL MEDICAL CENTER
发明人:
Bruce C Trapnell,Takuji Suzuki,Thomas Moritz,Nico Lachmann,Axel Schambach
申请号:
US16613592
公开号:
US20200199623A1
申请日:
2018.05.16
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The disclosure provides compositions and methods for cell therapy of hPAP in humans using gene corrected and in vitro differentiated patient autologous macrophage cells. The disclosure also provides compositions in the form of a cell product and related compositions and methods for making the cell product and for direct pulmonary transplantation of same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充